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Detection of Residual Brain Arteriovenous
Malformations after Radiosurgery:
Diagnostic Accuracy of Contrast-Enhanced
Three-Dimensional Time of Flight MR
Angiography at 3.0 Tesla
Objective: Although three-dimensional time-of-flight magnetic resonance
angiography (3D TOF-MRA) is used frequently as a follow-up tool to assess the
response of arteriovenous malformations (AVMs) after radiosurgery, the diagnos-
tic accuracy of 3D TOF-MRA is not well known. We evaluated the diagnostic
accuracy of contrast-enhanced 3D TOF-MRA at 3.0 Tesla for the detection of
residual AVMs.
Materials and Methods: This study included 32 AVMs from 32 patients who
had been treated with radiosurgery (males/females: 21/11; average patient age,
33.1 years). The time interval between radiosurgery and MRA was an average of
35.3 months (range, 12-88 months). Three-dimensional TOF-MRA was obtained
at a magnetic field strength of 3.0 Tesla after infusion of contrast media, with a
measured voxel size of 0.40 × 0.80 × 1.4 (0.45) mm
3 and a reconstructed voxel
size of 0.27 × 0.27 × 0.70 (0.05) mm
3 after zero-filling. X-ray angiography was
performed as the reference of standard within six months after MRA (an average
of two months). To determine the presence of a residual AVM, the source images
of 3D TOF-MRA were independently reviewed, focusing on the presence of
abnormally hyperintense fine tangled or tubular structures with continuity as seen
on consecutive slices by two observers blinded to the X-ray angiography results.
Results: A residual AVM was identified in 10 patients (10 of 32, 31%) on X-ray
angiography. The inter-observer agreement for MRA was excellent (κ = 0.813).
For the detection of a residual AVM after radiosurgery as determined by observer
1 and observer 2, the source images of MRA had an overall sensitivity of
100%/90% (10 of 10, 9 of 10), specificity of 68%/68% (15 of 22, 15 of 22), positive
predictive value of 59%/56% (10 of 17, 9 of 16), negative predictive value of
100%/94% (15 of 15, 15 of 16) and diagnostic accuracy of 78%/75% (25 of 32, 24
of 32), respectively.
Conclusion: The sensitivity of contrast-enhanced 3D TOF-MRA at 3.0 Tesla is
high but the specificity is not sufficient for the detection of a residual AVM after
radiosurgery.
brain arteriovenous malformation (AVM) is an important cause of
intracranial hemorrhage, especially in young adults and children (1).
AVMs are usually treated with surgical resection, endovascular emboliza-
tion, radiosurgery or a combination of these methods (1-5). Radiosurgery has been
increasingly used for the treatment of small or residual AVMs after surgical resection
or embolization. After radiosurgery, microvascular structures within the AVM begin
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e-mail: cgchoi@amc.seoul.kr Ato be obliterated by endothelial cell damage and prolifera-
tion of smooth muscle cells, a process that usually contin-
ues for 2-3 years (6). Occasionally, complete obliteration
of an AVM has been reported several years after
radiosurgery (7-9). Recent studies have reported a
decreased but still remaining risk of hemorrhage during the
latency period (10, 11). Most physicians usually see
patients at follow-up at a regular interval to evaluate the
response to radiosurgery. As a follow-up imaging study, X-
ray angiography is the gold standard to evaluate the
response of an AVM to radiosurgery. However, invasive-
ness and potential neurological complications hinder the
use of X-ray angiography in routine follow-up studies (12,
13). In many institutions, non-invasive magnetic resonance
imaging (MRI) and magnetic resonance angiography
(MRA) have been frequently used as follow-up tools to
assess the response of AVMs and the adjacent brain
parenchyma (14-16).
Three-dimensional time-of-flight (3D TOF) MRA is a
commonly used technique for the delineation of an AVM
nidus during the planning of radiosurgery. However, the
diagnostic accuracy of 3D TOF-MRA for the detection of a
residual AVM after radiosurgery is not well known.
Previous studies with the use of the modality with a
magnetic field strength of 1.5 Tesla (T) have just
mentioned qualitatively the usefulness of 3D TOF-MRA
for monitoring the nidal response after radiosurgery, but
did not evaluate diagnostic performance of the technique
quantitatively (14, 15). Only a study by Mukherji et al.
(16) reported that the sensitivities of the use of 3D TOF-
MRA for small AVMs (< 1 cm) were 27% and 50% for
maximum intensity projection (MIP) and source images,
respectively. Although 3D dynamic MRA is an emerging
new technique, it has still limitations to detect a small
residual AVM due to relatively low spatial resolution (17).
Therefore, 3D TOF-MRA, which has higher spatial resolu-
tion than dynamic MRA, may be necessary to perform to
evaluate a radiosurgically treated AVM in detail. In this
study, we have attempted to determine whether contrast-
enhanced 3D TOF-MRA obtained at 3.0 T is sufficiently
accurate for the detection of a residual AVM after
radiosurgery.
MATERIALS AND METHODS
Patients
Patients met the following inclusion criteria: a patient
who had a brain AVM that was confirmed by conventional
X-ray angiography, treated with radiosurgery and
underwent both follow-up 3D TOF-MRA at 3.0 T and X-
ray angiography. From August 2005 to March 2008, 34
patients were identified from an MRA and gamma-knife
radiosurgery database. Two patients were excluded from
consideration because of more than a six-month interval
between follow-up MRA and X-ray angiography (seven
and 11 months, respectively). The remaining 32 patients
constituted the subjects for analysis in this study
(males/females, 21/11; age range 12-52 years; average
age, 33.1 years). Follow-up MRA was performed always
prior to X-ray angiography. MRA and X-ray angiography
were performed within six months (average interval, two
months). Radiosurgery and follow-up MRA were
performed within 12-88 months (average interval, 35.3
months).
Arteriovenous Malformation Characteristics and
Treatment
The locations of 32 AVMs were the frontal lobe (n = 5),
parietal lobe (n = 9), temporal lobe (n = 6), occipital lobe
(n = 3), corpus callosum (n = 3), basal ganglia (n = 3),
thalamus (n = 1), cerebellum (n = 1) and both the basal
ganglia and the thalamus (n = 1). The mean volume of an
AVM was 2.3 cm
3 (volume range, 0.1-11 cm
3). The
volume of an AVM before radiosurgery was calculated by
the use of GammaPlann software (version 5.3; Elekta
Instrument, Stockholm, Sweden). All patients were treated
using a Leksell gamma knife (Elekta Instrument) under
local anesthesia. A stereotactic head frame was used for
guiding and monitoring the treatment in all cases.
Radiation doses were 20-25 Gy/50-65% isodose at the
AVM margin. Thirteen patients were also treated by
embolization with coils or glue before or after gamma
knife radiosurgery.
Contrast-Enhanced 3D TOF-MRA and X-ray
Angiography Techniques
All follow-up MRA was performed with the use of a 3.0
T MRI system (Achieva, Philips Medical Systems, Best, The
Netherlands) using an 8-channel SENSE head coil. Axial
T2* gradient echo images were first obtained to identify
the presence or absence of a hemorrhagic event, with
TR/TE 900/16 milliseconds, flip angle 20 degrees, slice
thickness/gap 3/0 mm, slice number 30. Next, gadoterate
meglumine (0.1 mmol/kg Dotarem; Guerbet, Roissy,
France) was infused intravenously via the right antecubital
vein by use of an auto-injector (Medras; Medrad,
Indionola, PA) with an injection rate of 2-3 ml/sec
followed by a 15-20 ml saline flush at the same rate.
Contrast media was used to improve the visibility of small
arteries or veins of a residual AVM. One minute after
injection of contrast media, a 3D TOF-MRA scan was
started with imaging parameters as follows: a three-
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time/echo time, 25/3.45 milliseconds; flip angle, 20
degrees; field of view/rectangular field of view, 240
mm/80%; scan percentage, 50%; scan matrix/reconstruc-
tion matrix, 600/880; slice number/slice thickness/slice
overlap, 114/1.4 mm/50%; SENSE factor, 2 (right-left
direction); no vein saturation slab, magnetization transfer
or fat saturation pulse; optimized non-saturating excitation
(TONE) pulse; actual bandwidth, 108.6 Hertz/pixel. The
imaging parameters utilized yielded a measured voxel size
of 0.40 × 0.80 × 1.4 (0.45) mm
3 and a reconstructed
voxel size of 0.27 × 0.27 × 0.70 (0.05) mm
3 after zero-
filling of an 880 matrix along frequency and phase
directions. The acquisition time was 4 minutes 26 seconds.
A total of 114 slices were sampled in three slabs using
CHARM (chunk acquisition and reconstruction method;
Philips Medical Systems) to avoid venetian blind artifacts.
The scan range was 80 mm and covered an AVM in the
central portion of the scan range in most patients.
X-ray angiography was performed with use of a biplane
Integris BN 3000 system (Philips Medical Systems). A 4-Fr
headhunter catheter was introduced into the ascending
aorta via the transfemoral route and was navigated into
the carotid or vertebral artery. The appropriate carotid or
vertebral artery was selected according to the decision of
the angiographer. The intracranial arteries were displayed
in at least two projections, i.e. anterior-posterior and
lateral, by automatic injection of 6-8 mL of iodixanol (320
mg iodine/ml, Visipaque; Amersham, Cork, Ireland). X-ray
angiography was performed with a 178 mm or 229 mm (7
or 9 inches) field of view and a 1,024 matrix, yielding a
measured pixel size of 0.17 × 0.17 mm
2 or 0.22 ×0.22
mm
2, respectively. Our Institutional Review Board
approved the study protocol and the requirement for
patient written informed consent was waived.
Image Analysis
Two observers, a neuroradiologist who had more than
10 years experience in the interpretation of 3D TOF-MRA
and a fourth year resident of radiology assessed the source
images of 3D TOF-MRA independently and without
knowledge of the follow-up X-ray angiography results.
Special attention was paid to the presence or absence of
abnormal vascular structures, suggestive of a residual AVM
nidus or draining veins. Abnormal vascular structures were
defined as abnormal hyperintense fine tangled structures
or tubular structures with continuity as seen on consecu-
tive slices. Irregular or nodular hyperintense lesions
without a branching pattern were regarded as radiation-
induced parenchymal enhancement (RIPE). Follow-up X-
ray angiographic images were analyzed based on the
consensus of an experienced neuroradiologist and a
neurosurgeon with more than 10 years experience in the
practice of neuroangiography and radiosurgery of AVMs,
respectively. The absence of early draining veins was
regarded as complete obliteration of an AVM. The
presence of residual ectatic vessels or angiomatous changes
around the obliterated nidus was not regarded as due to
the presence of a residual AVM. The presence of an early
draining vein with or even without a definitely visible
nidus was regarded as incomplete obliteration or as due to
a residual AVM. The volume of a residual AVM was
estimated from the source images of 3D TOF-MRA by
using a PACS (Picture Archiving and Communication
System; Petavision, Asan Medical Center, Seoul). The
inter-observer agreement rate was calculated by the use of
kappa (κ ) statistics and sensitivity, specificity, positive
predictive value (PPV), negative predictive value (NPV)
and diagnostic accuracy of 3D TOF-MRA for the detection
of a residual AVM after radiosurgery were determined.
RESULTS
As depicted on follow-up X-ray angiography, 10 patients
had a residual AVM nidus or early draining vein. The
remaining 22 patients had no residual AVM. The mean
volume of a residual AVM was 0.28 cm
3 (range 0.06-0.65
cm
3). For all patients, the quality of 3D TOF-MRA was
adequate or sufficient for diagnosis. Inter-observer
agreement of 3D TOF-MRA was excellent (κ = 0.813). As
determined by observer 1 and observer 2, the source
images of 3D TOF-MRA had overall sensitivity of
100%/90% (10 of 10, 9 of 10), specificity of 68%/68%
(15 of 22, 15 of 22), PPV of 59%/56% (10 of 17, 9 of 16),
NPV of 100%/94% (15 of 15, 15 of 16) and diagnostic
accuracy of 78%/75% (25 of 32, 24 of 32), respectively,
for the detection of a residual AVM nidus or draining veins
after radiosurgery (Table 1).
Typical true positive and true negative cases are
presented in Figures 1 and 2, respectively. With the use of
3D TOF-MRA, observers 1 and 2 considered seven and
seven patients, respectively, as having a residual AVM, but
the patients showed completely obliterated AVMs on
follow-up X-ray angiography (Fig. 3). Of these patients, six
patients showed overlapping findings. Observer 2 consid-
ered one patient as having complete obliteration with
RIPE, but follow-up X-ray angiography demonstrated the
presence of a residual AVM nidus with early draining veins
(Fig. 4). This situation was due to an interpretation error
by observer 2 and was the only false negative case as
identified by both observers. The false positive and false
negative results for the use of 3D TOF-MRA are
Residual Brain AVM after Radiosurgery and Contrast-Enhanced 3D TOF MR Angiography
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DISCUSSION
Our study showed that contrast-enhanced 3D TOF-MRA
performed at 3.0 T has a high sensitivity (90-100%), but a
relatively low specificity (68%) for the detection of a
residual AVM after gamma-knife radiosurgery. The high
sensitivity may be due to the improved spatial resolution
of 3D TOF-MRA performed at 3.0 T (18, 19). The infusion
of contrast media may also improve the vessel-background
tissue contrast and the depiction of small vessel segments.
These features allowed the sensitive detection of abnormal
vascular structures that were suggestive of a residual AVM
nidus or draining veins. Specificity was lower than
expected due to the inclusion of eight patients with false-
Lee et al.
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AB
Fig. 2. Findings for typical true negative
case. 21-year-old man had ruptured
arteriovenous malformation located at
left parietal lobe and was treated with
gamma-knife 28 months prior. 
A. Source image of 3D TOF-MRA
shows large encephalomalatic change
and focal mild brain parenchymal
enhancement without branching pattern
(arrows) in left medial parietal lobe,
which was interpreted as due to
complete obliteration of arteriovenous
malformation by both observers. 
B. On left internal carotid and vertebral
angiogram (not shown here), no residual
arteriovenous malformation or early
draining vein is seen.
AB
Table 1. Comparison of 3D TOF-MRA with X-ray Angiography
X-ray Angiography
Residual AVM Obliterated AVM Total
3D TOF-MRA by Observer 1 Residual AVM 10 071 7
Obliterated AVM 001 5 1 5
Total 10 22 32
3D TOF-MRA by Observer 2 Residual AVM 09 071 6
Obliterated AVM 011 5 1 6
Total 10 22 32
Note.─ 3D TOF-MRA = three-dimensional time-of-flight magnetic resonance angiography, AVM = arteriovenous malformation
Fig. 1. Findings for typical true positive
case. 45-year-old woman had ruptured
arteriovenous malformation located at
right medial temporo-occipital lobe and
was treated with gamma-knife 46
months prior. 
A. Source image of 3D TOF-MRA
shows entangled tubular enhancing
lesions (arrows) in right medial temporo-
occipital lobe, which were interpreted as
due to presence of residual arteriove-
nous malformation with draining vein by
both observers. 
B. Lateral view of right internal carotid
angiogram demonstrates presence of
residual arteriovenous malformation
(arrows) with early draining vein
(arrowheads).positive results from the use of 3D TOF-MRA (Table 2). In
our experience, the most important cause of false positive
results was the presence of persistent ectatic vessels around
the obliterated nidus rather than RIPE. Frequently,
residual ectatic vessels were mixed with RIPE and the
resulting pattern mimicked a residual AVM. Residual
ectasia of former afferent or efferent vessels can persist
adjacent to an AVM, even after transnidus flow has been
eliminated (20). These residual ectatic vessels can be
misinterpreted as feeding arteries or as early draining veins
that are suggestive of a residual AVM. This situation seems
to be an unavoidable limitation of 3D TOF-MRA, which is
not a dynamic study. The use of dynamic MRA can be
added to 3D TOF-MRA to solve this kind of problem (17,
21). Sufficient spatial and temporal resolution to distin-
guish residual ectatic vessels with a true residual AVM is
required. For dynamic MRA, temporal resolution should
be less than one second to detect early draining veins
Residual Brain AVM after Radiosurgery and Contrast-Enhanced 3D TOF MR Angiography
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ABC
Fig. 4. Findings for false negative case
by observer 2. 18-year-old woman had
arteriovenous malformation at right
frontal lobe and was treated by gamma-
knife 88 months prior. 
A. Source image of 3D TOF-MRA
shows fine reticular enhancing lesion
(arrows) located at posterior margin of
encephalomalatic change. Observer 2
interpreted this case as due to complete
obliteration of arteriovenous malforma-
tion with radiation change. 
B. Right internal carotid angiogram
demonstrates presence of residual
arteriovenous malformation (arrows)
with early draining vein (arrowheads).
AB
Fig. 3. Findings for false positive case. 51-year-old man had arteriovenous malformation located at left parietal lobe and was treated by
gamma-knife 18 months prior. 
A. Source image of 3D TOF-MRA shows irregular parenchymal enhancement and tubular enhancing vessels located at left parietal lobe
(arrows). Both observers interpreted this case as due to presence of residual arteriovenous malformation. 
B, C. On left internal carotid angiogram, no residual arteriovenous malformation is seen but still persistent ectasia of feeding artery and
abnormal small vein (arrowheads) are seen.confidently. As spatial resolution of dynamic MRA is
usually related reciprocally with temporal resolution, it
may be difficult to detect a small residual AVM by the use
of dynamic MRA with high temporal resolution. However,
the combination of 3D TOF-MRA with dynamic MRA
seems to be the current best option. Further investigations
may be necessary to evaluate the role of the use of
dynamic MRA for the detection of the small sized residual
AVMs included in this study.
Another possible cause of false positive results of 3D
TOF-MRA was the relatively long follow-up interval
between the use of 3D TOF-MRA and X-ray angiography
(with a maximum of six months). A small residual AVM
could be obliterated during the follow-up period between
the use of 3D TOF-MRA and X-ray angiography.
The high NPV of 3D TOF-MRA is of interest. In this
study, only one false negative result of 3D TOF-MRA (Fig.
4) was obtained. Observer 2 interpreted the fine reticular
enhancing lesion located at the posterior margin of
encephalomalatic change as due to a radiation change.
However, on a retrospective review, the source images
showed the presence of clearly abnormal vessels with
branching patterns on consecutive slices (an interpretation
error of observer 2). This experience suggests that the
interpreter should be careful in assessing the source images
of 3D TOF-MRA to differentiate RIPE from a residual
AVM. RIPE near or within the AVM nidus can be seen for
several years, even after successful obliteration of an AVM
(7). This situation may be due to disruption of the blood-
brain barrier or may be due to radiation necrosis.
The high NPV of contrast-enhanced 3D TOF-MRA can
decrease the need for X-ray angiography to confirm AVM
obliteration. The use of X-ray angiography can be
probably limited to patients who are suspected as having a
residual AVM as depicted on 3D TOF-MRA after the
latency period.
Several studies have analyzed the ability of MR imaging
and MRA to detect obliteration of the AVM nidus after
radiosurgery (7, 8, 14-16, 21-24). Mukherji et al. (16)
analyzed the sensitivity of 3D TOF-MRA to detect a small-
volume AVM in 33 patients. These investigators reported a
sensitivity of 27% and 50% for MIP and source images,
respectively, for the detection of mean nidus diameters less
than 1 cm. The low sensitivity may be due to low spatial
resolution and weak flow signal obtained from a low field
strength MRI system (1.0 T). Pollock et al. (22) analyzed
the diagnostic accuracy of spin-echo MR imaging in
comparison to conventional cerebral angiography to
evaluate AVMs after radiosurgery in 164 patients. These
investigators reported sensitivity of 80%, specificity of
100%, PPV of 100%, NPV of 84% and  overall accuracy
of 90% for the detection of a residual AVM. This differ-
ence of diagnostic performance between the use of
contrast-enhanced 3D TOF-MRA and spin-echo MR
imaging may be related to various factors such as the use
of contrast media, spatial resolution of imaging techniques
and the sizes of the residual AVMs.
Our study had several limitations. The study was not
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Table 2. Summary of False Positive or False Negative Cases as Determined on 3D TOF-MRA
Cases Observer 1 Observer 2 X-ray Angiography Estimated Causes
False Positive 1 M/51, left  Residual AVM Residual AVM Complete  Persistent ectatic 
frontal lobe obliteration vessels + RIPE
False Positive 2 M/53, right BG,  Residual AVM Residual AVM Complete  Persistent ectatic 
thalamus obliteration vessels + RIPE
False Positive 3 M/22, right  Residual AVM Residual AVM Complete  Persistent ectatic 
frontal lobe obliteration vessels + RIPE
False Positive 4 M/37, right  Residual AVM Residual AVM Complete  Persistent ectatic 
thalamus obliteration vessels + RIPE
False Positive 5 M/36, left  Complete  Residual AVM Complete  Persistent ectatic 
frontal lobe obliteration obliteration vessels + RIPE 
False Positive 6 F/12, right  Residual AVM Residual AVM Complete  Persistent ectatic 
parietal lobe obliteration vessels + RIPE
False Positive 7 M/43, left BG Residual AVM Residual AVM Complete  Persistent ectatic 
obliteration vessels + RIPE 
False Positive 8 F/43, right  Residual AVM Complete  Complete  Persistent ectatic 
parietal lobe obliteration obliteration vessels + RIPE 
False Negative 1 F/18, right  Residual AVM Complete  Residual AVM Interpretation 
frontal lobe obliteration error
Note.─ AVM = arteriovenous malformation, BG = basal ganglia, RIPE = radiation-induced parenchymal enhancement designed to compare pre-contrast and post-contrast 3D
TOF-MRA. A comparison between pre-contrast and post-
contrast 3D TOF-MRA would allow easier differentiation
of RIPE with abnormal vascular structures. Another limita-
tion was the long follow-up interval between 3D TOF-
MRA and X-ray angiography, up to six months.
In conclusion, contrast-enhanced 3D TOF-MRA at 3.0 T
is highly sensitive but not highly specific for the detection
of a small residual AVM after radiosurgery. Therefore,
conventional X-ray angiography is still necessary to
perform to confirm the status of an AVM after the latency
period of radiosurgery.
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